These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37287266)

  • 21. Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers.
    Vettorazzi M; Stocco C; Chirico A; Recanatini S; Saccon S; Mariotto R; Cinquetti S; Moretto T; Sartori P; Stomeo A; Ciatto S
    Tumori; 2006; 92(1):1-5. PubMed ID: 16683376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
    Lee JM; Ichikawa LE; Wernli KJ; Bowles E; Specht JM; Kerlikowske K; Miglioretti DL; Lowry KP; Tosteson ANA; Stout NK; Houssami N; Onega T; Buist DSM
    Radiology; 2021 Aug; 300(2):290-300. PubMed ID: 34003059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands).
    Aarts A; Duffy SW; Geurts S; Vulkan DP; Otten J; Hsu CY; Chen T; Verbeek A; Broeders M
    J Med Screen; 2019 Sep; 26(3):147-153. PubMed ID: 30541383
    [No Abstract]   [Full Text] [Related]  

  • 25. A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer.
    Dreher N; Matthys M; Hadeler E; Shieh Y; Acerbi I; McAuley FM; Melisko M; Eklund M; Tice JA; Esserman LJ; Veer LJV
    Breast Cancer Res Treat; 2022 Feb; 191(3):623-629. PubMed ID: 34843026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.
    Brekelmans CT; Westers P; Faber JA; Peeters PH; Collette HJ
    J Epidemiol Community Health; 1996 Feb; 50(1):68-71. PubMed ID: 8762357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
    van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.
    Fenton JJ; Onega T; Zhu W; Balch S; Smith-Bindman R; Henderson L; Sprague BL; Kerlikowske K; Hubbard RA
    Med Care; 2016 Mar; 54(3):e15-22. PubMed ID: 23929404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.
    Salim M; Dembrower K; Eklund M; Lindholm P; Strand F
    Radiology; 2020 Oct; 297(1):33-39. PubMed ID: 32720866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
    Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
    J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying women with dense breasts at high risk for interval cancer: a cohort study.
    Kerlikowske K; Zhu W; Tosteson AN; Sprague BL; Tice JA; Lehman CD; Miglioretti DL;
    Ann Intern Med; 2015 May; 162(10):673-81. PubMed ID: 25984843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49.
    Duffy SW; Chen HH; Tabar L; Fagerberg G; Paci E
    Int J Epidemiol; 1996 Dec; 25(6):1139-45. PubMed ID: 9027517
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.